Neurological Biomarker Market Forecast to 2027 - PowerPoint PPT Presentation

About This Presentation
Title:

Neurological Biomarker Market Forecast to 2027

Description:

Neurological Biomarker Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Others); Application (Alzheimer's Disease, Parkinson's Disease, Schizophrenia, Huntington's Disease, Spinal Muscular Atrophy, Others); End User (Pharmaceutical and Biotechnology Companies, Clinical Diagnostics, Research Organizations); and Geography – PowerPoint PPT presentation

Number of Views:3
Slides: 6
Provided by: lisaseghers7
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Neurological Biomarker Market Forecast to 2027


1
Neurological Biomarker Market 
Neurological Biomarker Market Forecast to 2027 -
COVID-19 Impact and Global Analysis by Product
(Proteomics Biomarker, Genomics Biomarker,
Metabolomics Biomarker, Imaging Biomarker,
Others) Application (Alzheimer's Disease,
Parkinson's Disease, Schizophrenia, Huntington's
Disease, Spinal Muscular Atrophy, Others) End
User (Pharmaceutical and Biotechnology Companies,
Clinical Diagnostics, Research Organizations)
and Geography
2
Current and future Market Scenario
Neurological Biomarker Market 
  • According to our new market research study on
    Neurological Biomarker Market to 2028 Global
    Analysis and Forecast by Type, Treatment, and
    End User, the market is expected to reach US
    14,454.7 million by 2027 from US 5,501.8 million
    in 2019. The market is estimated to grow at a
    CAGR of 13.0 from 2020 to 2027.
  • The genomic biomarkers segment held the largest
    share of the global neurological biomarker
    market, based on product, in 2019, and it is
    expected to register the highest CAGR during the
    forecast period. This segment is likely to
    witness a lucrative growth owing to increasing
    consumer awarenessabout the benefits of genetic
    medicines as well as technological advancements
    in the field of neurological biomarkers.

3
Market Segments
Neurological Biomarker Market   
By Product Proteomics Biomarker Genomics
Biomarker Metabolomics Biomarker Imaging
Biomarker Others
By End User Pharmaceutical and Biotechnology
Companies Clinical Diagnostics Research
Organizations
By Application Alzheimer's Disease Parkinson's
Disease Schizophrenia Huntington's Disease Spinal
Muscular Atrophy Others
4
Leading Players
Neurological Biomarker Market  
Company Profiles in Neurological Biomarker
Market are Thermo Fisher Scientific
Inc. Abbott Myriad Genetics, Inc. Bio-Rad
Laboratories Inc. QIAGEN Banyan Biomarkers,
Inc Immunarray Pvt. Ltd. Quest Diagnostics
Incorporated Perkin Elmer, Inc. MERCK KGaA
5
Neurological Biomarker Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/neurolo
gical-biomarker-market
Thank You!
  • Thank You!
Write a Comment
User Comments (0)
About PowerShow.com